Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria
Despite limitations, our matching-adjusted indirect comparison analysis highlights that omalizumab is an effective treatment option for appropriate patients with chronic spontaneous urticaria.
Authors
- Arpamas Seetasith
- Giselle Mosnaim
- Benjamin L. Trzaskoma
- Michael Holden
- Sarbjit S. Saini
Institutions
- Johns Hopkins University (US)
- Illinois Tool Works (United States) (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1016/j.jacig.2026.100668
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00